awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35074974-D82BD965-236A-4483-90C1-AD67695C7069
Q35074974-D82BD965-236A-4483-90C1-AD67695C7069
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35074974-D82BD965-236A-4483-90C1-AD67695C7069
Pazopanib exposure decreases as a result of an ifosfamide-dependent drug-drug interaction: results of a phase I study
P2860
Q35074974-D82BD965-236A-4483-90C1-AD67695C7069
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35074974-D82BD965-236A-4483-90C1-AD67695C7069
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e7b85c5725522c8f51ad33896efb3a0e303e6dfd
P2860
Phase I study of pazopanib in combination with paclitaxel and carboplatin given every 21 days in patients with advanced solid tumors.